Eh. Karran et al., A SIMPLE IN-VIVO MODEL OF COLLAGEN DEGRADATION USING COLLAGEN-GELLED COTTON BUDS - THE EFFECTS OF COLLAGENASE INHIBITORS AND OTHER AGENTS, Inflammation research, 44(1), 1995, pp. 36-46
A simple in vivo model of collagen degradation has been developed, and
the effects of various agents have been tested. Type I collagen was p
repared from rat skin and acetylated with either [H-3]- or [C-14] acet
ic anhydride. The radiolabelled collagen was added to sterile cotton b
uds and incubated at 37 degrees C to allow the collagen to form native
fibrils that were firmly adsorbed to the cotton matrix. After subcuta
neous implantation of the collagen-gelled cotton buds into rats, the r
adiolabelled collagen was progressively removed over a period of weeks
by an infiltrating granuloma. Of the agents that were administered di
rectly into the cotton buds using subcutaneously implanted osmotic min
i-pumps, only the synthetic collagenase inhibitors CI-A (containing a
hydroxamate moiety as a zinc ligand) and CI-C (containing a thiol moie
ty as a zinc ligand) were able to prevent the removal of collagen: the
ir efficacy correlated with the level of collagenase inhibitory activi
ty assayed in the exudate fluid sequestered within the cotton bud gran
uloma. Of the agents that were administered systemically, including an
ti-inflammatory drugs and other compounds used as therapies for arthri
tis, only hydrocortisone was able to inhibit the removal of radiolabel
led collagen. These results suggest that, in this model, interstitial
collagenase, a member of the matrix metalloproteinase family, comprise
d the major degradative pathway for collagen. The collagen-gelled cott
on bud model is a useful test system for delineating those processes t
hat result in collagen catabolism. In addition, the model can be used
for testing agents, including those of limited or unknown systemic bio
availability, in order to discover novel therapeutic agents for preven
ting collagen degradation in connective tissue diseases such as arthri
tis.